Evaluation of risk of falls and orthostatic hypotension in older, long-term topical beta-blocker users

Graefe's Archive for Clinical and Experimental Ophthalmology

Volumn 247, Issue 9, 2009, Pages 1235-1241

  Ramdas, Wishal D ^a   van der Velde, Nathalie ^a   van der Cammen, Tischa J M ^a   Wolfs, Roger C W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Beta blocker; Falls; Glaucoma; Ocular hypertension; Orthostatic hypotension; Prostaglandins; Treatment

Indexed keywords

ANALGESIC AGENT; ANTIARRHYTHMIC AGENT; ANTIDEPRESSANT AGENT; ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; BIMATOPROST; CARTEOLOL; DORZOLAMIDE; DORZOLAMIDE PLUS TIMOLOL; LATANOPROST; LATANOPROST PLUS TIMOLOL; NEUROLEPTIC AGENT; NITRIC ACID DERIVATIVE; PROSTAGLANDIN; SEDATIVE AGENT; SPASMOLYTIC AGENT; TIMOLOL MALEATE; TIMOLOL PLUS TRAVOPROST; TRAVOPROST;

ADULT; AGED; ARTICLE; BLOOD PRESSURE MEASUREMENT; CONTROLLED STUDY; DIZZINESS; FALL RISK; FALLING; FEMALE; HUMAN; INTERVIEW; INTRAOCULAR PRESSURE; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; ORTHOSTATIC HYPOTENSION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PULSE RATE; RISK ASSESSMENT; SIDE EFFECT;

ACCIDENTAL FALLS; ADMINISTRATION, TOPICAL; ADRENERGIC BETA-ANTAGONISTS; AGED; AGED, 80 AND OVER; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; FEMALE; GERIATRIC ASSESSMENT; GLAUCOMA; HEART RATE; HUMANS; HYPOTENSION, ORTHOSTATIC; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OCULAR HYPERTENSION; ODDS RATIO; OPHTHALMIC SOLUTIONS; QUESTIONNAIRES; RISK ASSESSMENT;

EID: 68549099676     PISSN: 0721832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00417-009-1092-8     Document Type: Article

References (38)

1. Maier PC, Funk J, Schwarzer G, Antes G, Falck-Ytter YT (2005) Treatment of ocular hypertension and open angle glaucoma: Meta-analysis of randomised controlled trials. BMJ 331:134
2. Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M (2002) Reduction of intraocular pressure and glaucoma progression: Results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 120:1268-1279
3. Diggory P, Franks WA (1997) Glaucoma therapy may take your breath away. Age Ageing 26:63-67. doi: 10.1093/ageing/26.2.63
4. Munroe WP, Rindone JP, Kershner RM (1985) Systemic side effects associated with the ophthalmic administration of timolol. Drug Intel Clin Pharm 19:85-89
5. Novack GD, O'Donnell MJ, Molloy DW (2002) New glaucoma medications in the geriatric population: Efficacy and safety. J Am Geriatr Soc 50:956-962. doi: 10.1046/j.1532-5415.2002.50226.x
6. Detry-Morel M (2006) Side effects of glaucoma medications. Bull Soc Belge Ophtalmol 299:27-40
7. Stewart WC, Garrison PM (1998) Beta-blocker-induced complications and the patient with glaucoma. Newer treatments to help reduce systemic adverse events. Arch Intern Med 158:221-226. doi: 10.1001/ archinte.158.3.221
8. Muller ME, van der Velde N, Krulder JW, van der Cammen TJ (2006) Syncope and falls due to timolol eye drops. BMJ 332:960-961
9. American Geriatrics Society, British Geriatrics Society, and American Academy of Orthopaedic Surgeons Panel on Falls Prevention (2001) Guideline for the prevention of falls in older persons. J Am Geriatr Soc 49:664-672. doi: 10.1046/j.1532-5415.2001.49115.x
10. Leipzig RM, Cumming RG, Tinetti ME (1999) Drugs and falls in older people: A systematic review and meta-analysis: II. Cardiac and analgesic drugs. J Am Geriatr Soc 47:40-50
11. Leipzig RM, Cumming RG, Tinetti ME (1999) Drugs and falls in older people: A systematic review and meta-analysis: I. Psychotropic drugs. J Am Geriatr Soc 47:30-39
12. Ziere G, Dieleman JP, Hofman A, Pols HA, van der Cammen TJ, Stricker BH (2006) Polypharmacy and falls in the middle aged and elderly population. Br J Clin Pharmacol 61:218-223. doi: 10.1111/j.1365-2125.2005.02543.x
13. Campbell AJ, Robertson MC, Gardner MM, Norton RN, Buchner DM (1999) Psychotropic medication withdrawal and a home-based exercise program to prevent falls: A randomized, controlled trial. J Am Geriatr Soc 47:850-853
14. van der Velde N, Stricker BH, Pols HA, van der Cammen TJ (2007) Risk of falls after withdrawal of fall-risk-increasing drugs: A prospective cohort study. Br J Clin Pharmacol 63:232-237. doi: 10.1111/ j.1365-2125.2006.02736.x
15. van der Velde N, Ziere G, van der Cammen TJ (2004) Falls in three patients due to timolol eye drops, tolterodine, and flecainide. J Gerontol A Biol Sci Med Sci 59:1343-1344
16. Everitt DE, Avorn J (1990) Systemic effects of medications used to treat glaucoma. Ann Intern Med 112:120-125
17. Black A, Wood J (2005) Vision and falls. Clin Exp Optom 88:212-222
18. van der Valk R, Webers CA, Hendrikse F, de Vogel SC, Prins MH, Schouten JS (2007) Predicting intraocular pressure change before initiating therapy: Timolol versus latanoprost. Acta Ophthalmol 86(4):415-418
19. van der Valk R, Webers CA, Schouten JS, Zeegers MP, Hendrikse F, Prins MH (2005) Intraocular pressure-lowering effects of all commonly used glaucoma drugs: A meta-analysis of randomized clinical trials. Ophthalmology 112:1177-1185. doi: 10.1016/j.ophtha.2005.01.042
20. Campbell AJ, Reinken J, Allan BC, Martinez GS (1981) Falls in old age: A study of frequency and related clinical factors. Age Ageing 10:264-270. doi: 10.1093/ageing/10.4.264
21. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology (1996) Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. Neurology 46:1470
22. Wong SN, Tz Sung RY, Leung LC (2006) Validation of three oscillometric blood pressure devices against auscultatory mercury sphygmomanometer in children. Blood Press Monit 11:281-291. doi: 10.1097/ 01.mbp.0000209082.09623.b4
23. White WB, Herbst T, Thavarajah S, Giacco S (2003) Clinical evaluation of the Trimline blood pressure cuffs with the Accutorr Plus Monitor. Blood Press Monit 8:137-140
24. Lama PJ (2002) Systemic adverse effects of beta-adrenergic blockers: An evidence-based assessment. Am J Ophthalmol 134:749-760. doi: 10.1016/ S0002-9394(02)01699-9
25. Waldock A, Snape J, Graham CM (2000) Effects of glaucoma medications on the cardiorespiratory and intraocular pressure status of newly diagnosed glaucoma patients. Br J Ophthalmol 84:710-713. doi: 10.1136/bjo.84.7.710
26. Kirwan JF, Nightingale JA, Bunce C, Wormald R (2002) Beta blockers for glaucoma and excess risk of airways obstruction: Population based cohort study. BMJ 325:1396-1397
27. Frishman WH, Kowalski M, Nagnur S, Warshafsky S, Sica D (2001) Cardiovascular considerations in using topical, oral, and intravenous drugs for the treatment of glaucoma and ocular hypertension: Focus on beta-adrenergic blockade. Heart Dis 3:386-397
28. Vander Zanden JA, Valuck RJ, Bunch CL, Perlman JI, Anderson C, Wortman GI (2001) Systemic adverse effects of ophthalmic beta-blockers. Ann Pharmacother 35:1633-1637. doi: 10.1345/aph.18464
29. Diggory P, Cassels-Brown A, Fernandez C (1996) Topical beta-blockade with intrinsic sympathomimetic activity offers no advantage for the respiratory and cardiovascular function of elderly people. Age Ageing 25:424-428. doi: 10.1093/ageing/25.6.424
30. Kirwan JF, Nightingale JA, Bunce C, Wormald R (2004) Do selective topical beta antagonists for glaucoma have respiratory side effects? Br J Ophthalmol 88:196-198. doi: 10.1136/bjo.2003.017715
31. Diggory P, Cassels-Brown A, Vail A, Hillman JS (1998) Randomised, controlled trial of spirometric changes in elderly people receiving timolol or betaxolol as initial treatment for glaucoma. Br J Ophthalmol 82:146-149. doi: 10.1136/bjo.82.2.146
32. Leier CV, Baker ND, Weber PA (1986) Cardiovascular effects of ophthalmic timolol. Ann Intern Med 104:197-199
33. Kaila T, Huupponen R, Karhuvaara S, Havula P, Scheinin M, Iisalo E, Salminen L (1991) Beta-blocking effects of timolol at low plasma concentrations. Clin Pharmacol Ther 49:53-58
34. Vuori ML, Kaila T (1995) Plasma kinetics and antagonist activity of topical ocular timolol in elderly patients. Graefes Arch Clin Exp Ophthalmol 233:131-134
35. Cummings SR, Nevitt MC, Kidd S (1988) Forgetting falls. The limited accuracy of recall of falls in the elderly. J Am Geriatr Soc 36:613-616
36. Brignole M, Alboni P, Benditt D, Bergfeldt L, Blanc JJ, Bloch Thomsen PE, Fitzpatrick A, Hohnloser S, Kapoor W, Kenny RA, Theodorakis G, Kulakowski P, Moya A, Raviele A, Sutton R, Wieling W, Janousek J, van Dijk G (2001) Task force on syncope, European Society of Cardiology. Part 1. The initial evaluation of patients with syncope. Europace 3:253-260. doi: 10.1053/eupc.2001.0190
37. Brignole M, Alboni P, Benditt D, Bergfeldt L, Blanc JJ, Bloch Thomsen PE, Fitzpatrick A, Hohnloser S, Kapoor W, Kenny RA, Theodorakis G, Kulakowski P, Moya A, Raviele A, Sutton R, Wieling W, Janousek J, van Dijk G (2001) Task force on syncope, European Society of Cardiology. Part 2. Diagnostic tests and treatment: Summary of recommendations. Europace 3:261-268. doi: 10.1053/eupc.2001.0191
38. Brignole M (2007) Diagnosis and treatment of syncope. Heart 93:130-136. doi: 10.1136/hrt.2005.080713